Faculty Opinions recommendation of Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer).

2007 ◽  
Author(s):  
Richard Sampliner
Keyword(s):  
Endoscopic Resection ◽  
Barrett’S Cancer

Quantitative analysis of submucosal excision depth in endoscopic resection for early Barrett’s cancer

Endoscopy ◽  
2021 ◽  
Author(s):  
Jenny Krause ◽  
Thomas Rösch ◽  
Stefan Steurer ◽  
Till Clauditz ◽  
Susanne Sehner ◽  
...  
Keyword(s):  
Quantitative Analysis ◽  
Endoscopic Submucosal Dissection ◽  
Endoscopic Resection ◽  
Early Stage ◽  
Accurate Assessment ◽  
Tissue Sections ◽  
Barrett’S Cancer ◽  
Neoplastic Lesions ◽  
Resection Area ◽  
Barrett’S Esophageal Adenocarcinoma

Background Following endoscopic resection of early-stage Barrett’s esophageal adenocarcinoma (BEA), further oncologic management then fundamentally relies upon the accurate assessment of histopathologic risk criteria, which requires there to be sufficient amounts of submucosal tissue in the resection specimens. Methods In 1685 digitized tissue sections from endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) performed for 76 early BEA cases from three experienced centers, the submucosal thickness was determined, using software developed in-house. Neoplastic lesions were manually annotated. Results No submucosa was seen in about a third of the entire resection area (mean 33.8 % [SD 17.2 %]), as well as underneath cancers (33.3 % [28.3 %]), with similar results for both resection methods and with respect to submucosal thickness. ESD results showed a greater variability between centers than EMR. In T1b cancers, a higher rate of submucosal defects tended to correlate with R1 resections. Conclusion The absence of submucosa underneath about one third of the tissue of endoscopically resected BEAs should be improved. Results were more center-dependent for ESD than for EMR. Submucosal defects can potentially serve as a parameter for standardized reports.

scholarly journals Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia

2020 ◽  
Vol 13 ◽  
pp. 263177452093524
Author(s):  
Oliver Pech ◽  
Saleh A. Alqahtani
Keyword(s):  
Radiofrequency Ablation ◽  
Endoscopic Resection ◽  
High Grade Dysplasia ◽  
Barrett’S Oesophagus ◽  
Low Grade ◽  
High Grade ◽  
Barrett's Oesophagus ◽  
Barrett’S Cancer ◽  
Visible Lesion ◽  
Low Grade Dysplasia

Endoscopic therapy of early Barrett’s oesophagus–related neoplasia is the treatment of choice for low-grade-dysplasia, high-grade dysplasia and mucosal Barrett’s cancer. Low-grade-dysplasia without any visible lesion should be ablated, preferably with radiofrequency ablation. In cases with the presence of a visible lesion, high-grade dysplasia and early Barrett’s adenocarcinoma, endoscopic resection techniques like multiband ligation endoscopic resection or endoscopic submucosal dissection should be applied. After complete resection of all visible neoplastic lesions, ablation of the remaining Barrett’s oesophagus should be performed to prevent recurrence. Ablation techniques available are radiofrequency ablation, argon plasma coagulation and cryoablation.

Tu1580 Early Barrett's Cancer With Incipient Submucosal Invasion (SM1): Results of Endoscopic Resection and Surgery

2012 ◽  
Vol 75 (4) ◽  
pp. AB453-AB454
Author(s):  
Hendrik Manner ◽  
Oliver Pech ◽  
Andrea May ◽  
Juergen Pohl ◽  
Michael Vieth ◽  
...  
Keyword(s):  
Endoscopic Resection ◽  
Submucosal Invasion ◽  
Barrett’S Cancer

Curative endoscopic resection of early esophageal adenocarcinomas (Barrett’s cancer)

2005 ◽  
Vol 43 (05) ◽  
Author(s):  
O Pech ◽  
L Gossner ◽  
A May ◽  
J Huijsmans ◽  
C Ell
Keyword(s):  
Endoscopic Resection ◽  
Barrett’S Cancer

Endoscopic resection for treatment of mucosal Barrett's cancer: time to swing the pendulum

2007 ◽  
Vol 65 (1) ◽  
pp. 11-13 ◽  
Author(s):  
Jacques J.G.H.M. Bergman
Keyword(s):  
Endoscopic Resection ◽  
Barrett’S Cancer

Endoscopic Resection for Mucosal Esophageal Cancer - Is There a Difference in Outcome Between Mucosal Barrett's Cancer and Mucosal Squamous Cell Cancer?

2009 ◽  
Vol 69 (5) ◽  
pp. AB347
Author(s):  
Oliver Pech ◽  
Hendrik Manner ◽  
Andrea May ◽  
Juergen Pohl ◽  
Christian Ell
Keyword(s):  
Esophageal Cancer ◽  
Endoscopic Resection ◽  
Squamous Cell ◽  
Squamous Cell Cancer ◽  
Cell Cancer ◽  
Barrett’S Cancer

719 Endoscopic Resection in 953 Patients With Mucosal Barrett's Cancer

2011 ◽  
Vol 73 (4) ◽  
pp. AB146 ◽  
Author(s):  
Oliver Pech ◽  
Andrea May ◽  
Hendrik Manner ◽  
Juergen Pohl ◽  
Christian Ell
Keyword(s):  
Endoscopic Resection ◽  
Barrett’S Cancer
Sign in / Sign up

Export Citation Format

Share Document